Summary Box: Amgen CEO Sees Higher Sales In 2012


Salon Staff
January 10, 2012 2:45AM (UTC)

RISING TIDE: Robert Bradway, on deck as Amgen's next CEO, predicts newer products and expanding operations into more countries to bring higher revenue down the road.

MOMENTUM: Positive developments include last year's purchase of a cancer vaccine developer and moves to protect long-term sales of top seller Enbrel, for psoriasis and rheumatoid arthritis, and anemia treatment Epogen.

Advertisement:

MANAGEMENT MOVES: Along with Bradway, Amgen has appointed new heads of commercial operations and research and development. It also plans more share buybacks.


Salon Staff

MORE FROM Salon Staff

BROWSE SALON.COM
COMPLETELY AD FREE,
FOR THE NEXT HOUR

Read Now, Pay Later - no upfront
registration for 1-Hour Access

Click Here
7-Day Access and Monthly
Subscriptions also available
No tracking or personal data collection
beyond name and email address

•••





Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •